GOLDMAN SACHS GROUP INC - SOLENO THERAPEUTICS INC ownership

SOLENO THERAPEUTICS INC's ticker is SLNO and the CUSIP is 834203200. A total of 63 filers reported holding SOLENO THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 4.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of SOLENO THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$124,000
+67.6%
109,382
+85.2%
0.00%
Q1 2021$74,000
-46.8%
59,077
-18.0%
0.00%
Q4 2020$139,000
-81.5%
72,075
-75.9%
0.00%
Q3 2020$751,000
+698.9%
299,253
+660.9%
0.00%
Q1 2020$94,00039,3270.00%
Other shareholders

There were no reported owners of SOLENO THERAPEUTICS INC in Q1 2021.

NameSharesValueWeighting ↓
View complete list of SOLENO THERAPEUTICS INC shareholders